ATC code L04
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
A section of the Anatomical Therapeutic Chemical Classification System.
L Antineoplastic and immunomodulating agents
L04A Immunosuppressive agents
L04AA Selective immunosuppressive agents
- L04AA01 Ciclosporin
- L04AA02 Muromonab-CD3
- L04AA03 Antilymphocyte immunoglobulin (horse)
- L04AA04 Antithymocyte immunoglobulin (rabbit)
- L04AA05 Tacrolimus
- L04AA06 Mycophenolic acid
- L04AA08 Daclizumab
- L04AA09 Basiliximab
- L04AA10 Sirolimus
- L04AA11 Etanercept
- L04AA12 Infliximab
- L04AA13 Leflunomide
- L04AA14 Anakinra
- L04AA15 Alefacept
- L04AA16 Afelimomab
- L04AA17 Adalimumab
- L04AA18 Everolimus
- L04AA19 Gusperimus
- L04AA21 Efalizumab
- L04AA22 Abetimus
- L04AA23 Natalizumab
L04AX Other immunosuppressive agents
- L04AX01 Azathioprine
- L04AX02 Thalidomide
- L04AX03 Methotrexatehu:ATC L04 – Immunszuppresszív szerekth:ATC รหัส L04
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
